Skip to content

Company information lookup

BONE MEDICAL LIMITED (BNE)

Development and commercialisation of treatments for bone disease

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
BNE 0.018 -10% 0.018 0.019 0.020 0.020 0.018 2,926,713
(Status - RE)

BONE MEDICAL LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code BNE
Securities
Official Listing Date 24 January, 1985
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address http://www.bone-ltd.com
Registered Office Address Ground Floor, 16 Ord Street, WEST PERTH, WA, AUSTRALIA, 6005
Head Office Telephone +61 8 9482 0580
Head Office Fax +61 8 9482 0505
Share Registry AUTOMIC REGISTRY SERVICES
LEVEL 1, 7 VENTNOR AVENUE, WEST PERTH, WA, AUSTRALIA, 6005
Share Registry Telephone (08) 9324 2099
Directors / Senior Management
Mr Robert Towner (Non Exec. Chairman)
Mr John Hannaford (Non Exec. Director)
Dr Roger New (Non Exec. Director)
Company Secretary Mr Phillip Wingate
Principal Activities Development and commercialisation of treatments for bone disease

BONE MEDICAL LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
28/08/2014 asterix Preliminary Final Report & Annual Report to Shareholders 73 PDF
28/08/2014   Less Than Marketable Parcel Share Sale Facility 2 PDF
15/08/2014   Change of Director's Interest Notice 5 PDF
31/07/2014   Quarterly Report 1 PDF
31/07/2014 asterix Appendix 4C - quarterly 5 PDF
09/07/2014   Expiry of Options & Change of Directors Interest Notice 3 PDF
02/07/2014 asterix Human Study Commences for Oral Treatment for Osteoporosis 2 PDF
19/06/2014 asterix Continuation of Studies for Rheumatoid Arthritis Treatment 3 PDF
13/05/2014   Final Director's Interest Notice 2 PDF
12/05/2014 asterix Approval Received to Commence Human Clinical Study 1 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
19 Sep 2014 0.020 0% 0.020 0.020 2,103,294
18 Sep 2014 0.020 0% 0.021 0.020 4,884,499
17 Sep 2014 0.020 0% 0.021 0.020 1,243,668
16 Sep 2014 0.020 -4.76% 0.022 0.020 2,523,582
15 Sep 2014 0.021 0% 0.022 0.021 2,141,000

* Volume of shares shown represents only those shares traded on ASX.

BONE MEDICAL LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security BNE. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security BNE

Warrants & Structured Products

No warrants & Structured Products are available over the security BNE

ASX CFDs

No Contracts For Differences are available over the security BNE